IMUX•benzinga•
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% In Primary Progressive Multiple Sclerosis Patients From Phase 2 CALLIPER Trial
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 30, 2025 by benzinga